Home › Companies › Cue Biopharma Inc.

Cue Biopharma Inc. (CUE) proxy voting records

How asset managers voted at Cue Biopharma Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.

TickerCUE
CUSIP issuer number22978P
SEC CIK1645460

Recent shareholder votes

June 5, 2024 annual meeting (2023-2024 proxy season): 8 items in Cue Biopharma Inc.'s official results (Form 8-K, filed June 7, 2024); lowest support 59% of votes cast (Elect Director: Frank Morich). Full results and how funds voted.

Each line is the company’s own Form 8-K tally as shown on that season’s page; support is FOR as a share of votes cast.

Proxy seasons

Season	Filed as	Ballot items	Asset managers
2023-2024	CUE BIOPHARMA INC.	8	90

Earlier seasons list this company under the name CUE BIOPHARMA INC., as its holders filed it.

Explore Cue Biopharma Inc. in the interactive database

The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. Ticker as listed by the SEC on November 6, 2026. This page is rebuilt weekly; built November 9, 2026.